Cargando…

Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant Klebsiella pneumoniae

Colistin- and carbapenem-resistant Enterobacteriaceae cases are increasing at alarming rates worldwide. Drug repurposing is receiving greater attention as an alternative approach in light of economic and technical barriers in antibiotics research. The immunomodulation agent ammonium trichloro(dioxoe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Tsung-Ying, Kao, Hao-Yun, Lu, Po-Liang, Chen, Pei-Yu, Wang, Shu-Chi, Wang, Liang-Chun, Hsieh, Ya-Ju, Tseng, Sung-Pin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400984/ https://www.ncbi.nlm.nih.gov/pubmed/34451891 http://dx.doi.org/10.3390/ph14080795

Ejemplares similares

Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae
por: Chang, Ya-Ting, et al.
Publicado: (2020)

Synergistic Combination of AS101 and Azidothymidine against Clinical Isolates of Carbapenem-Resistant Klebsiella pneumoniae
por: Sung, Chung-Lin, et al.
Publicado: (2021)

Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
por: Huang, Po-Han, et al.
Publicado: (2022)

Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in China
por: Weng, Yuesong, et al.
Publicado: (2023)

Novel Microwave-Assisted Synthesis of the Immunomodulator Organotellurium Compound Ammonium Trichloro(dioxoethylene-O,O′)tellurate (AS101)
por: Vázquez-Tato, M. Pilar, et al.
Publicado: (2014)

Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates
por: Lomonaco, Sara, et al.
Publicado: (2018)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant Acinetobacter baumannii
por: Yang, Tsung-Ying, et al.
Publicado: (2021)

Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae
por: Bir, Raunak, et al.
Publicado: (2022)

Emergence of Colistin Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Under the Pressure of Tigecycline
por: Zhang, Yawei, et al.
Publicado: (2021)

The threat of colistin resistance among carbapenem-resistant Klebsiella pneumoniae isolates in Iran
por: Haeili, Mehri, et al.
Publicado: (2018)

Investigation of double-carbapenem efficiency in experimental sepsis of colistin-resistant Klebsiella pneumoniae
por: Kosar, Imran, et al.
Publicado: (2021)

Heteroresistance Is Associated With in vitro Regrowth During Colistin Treatment in Carbapenem-Resistant Klebsiella pneumoniae
por: Wang, Yifan, et al.
Publicado: (2022)

Risk Factors for Colistin-Resistant Carbapenem-Resistant Klebsiella pneumoniae in the Postacute Care Setting
por: Zhang, Helen L, et al.
Publicado: (2022)

Molecular Characteristics and Quantitative Proteomic Analysis of Klebsiella pneumoniae Strains with Carbapenem and Colistin Resistance
por: Hao, Ling, et al.
Publicado: (2022)

Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro
por: Yu, Lan, et al.
Publicado: (2019)

Phenotypic Changes Associated With In Vivo Evolution of Colistin Resistance in ST11 Carbapenem-Resistant Klebsiella pneumoniae
por: Xie, Miaomiao, et al.
Publicado: (2022)

Genomic Epidemiology of Carbapenem- and Colistin-Resistant Klebsiella pneumoniae Isolates From Serbia: Predominance of ST101 Strains Carrying a Novel OXA-48 Plasmid
por: Palmieri, Mattia, et al.
Publicado: (2020)

Prolonged Outbreak of Carbapenem and Colistin-Resistant Klebsiella pneumoniae at a Large Tertiary Hospital in Brazil
por: Rocha, Verônica França Diniz, et al.
Publicado: (2022)

Carbapenem-resistant and carbapenem-susceptible isogenic isolates of Klebsiella pneumoniae ST101 causing infection in a tertiary hospital
por: Cubero, Meritxell, et al.
Publicado: (2015)

Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract
por: Zhang, Rong, et al.
Publicado: (2018)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

494. Fitness Cost of mcr-1-Mediated Colistin Resistance in Carbapenemase-Producing Klebsiella pneumoniae
por: Lin, Yi-Tsung, et al.
Publicado: (2019)

Unraveling the Organotellurium Chemistry Applied to the Synthesis of Gold Nanomaterials
por: Fernández-Lodeiro, Javier, et al.
Publicado: (2016)

In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains
por: Erdem, Fatma, et al.
Publicado: (2020)

In Vitro Evaluation of Tellurium-Based AS101 Compound against Neisseria gonorrhoeae Infectivity
por: Yang, Tsung-Ying, et al.
Publicado: (2023)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2020)

In vivo Emergence of Colistin and Tigecycline Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae During Antibiotics Treatment
por: Chen, Jiawei, et al.
Publicado: (2021)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Mantzana, Paraskevi, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Escherichia coli
por: Jitaree, Kamonchanok, et al.
Publicado: (2019)

In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1
por: Tang, Hung-Jen, et al.
Publicado: (2015)

In vivo Emergence of Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae Mediated by Premature Termination of the mgrB Gene Regulator
por: Kong, Yingying, et al.
Publicado: (2021)

Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant Klebsiella pneumoniae
por: Wang, Yu-Ping, et al.
Publicado: (2022)

Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
por: Wang, Zhe, et al.
Publicado: (2018)

The Occurence of Colistin-Resistant Hypervirulent Klebsiella pneumoniae in China
por: Lu, Yang, et al.
Publicado: (2018)

High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy
por: Shein, Aye Mya Sithu, et al.
Publicado: (2022)

Prevalence of the colistin resistance gene MCR-1 in colistin-resistant Klebsiella pneumoniae in Egypt
por: Abozahra, Rania, et al.
Publicado: (2023)

Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection
por: Band, Victor I., et al.
Publicado: (2018)

Emergence of Colistin and Carbapenem Resistance in Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Isolated from Chickens and Humans in Egypt
por: Elmonir, Walid, et al.
Publicado: (2021)

Successful management of colistin- and carbapenem-resistant Klebsiella pneumoniae-associated ecthyma gangrenosum in acute myeloid leukemia: A rare complication
por: Jamal, Aisha, et al.
Publicado: (2022)

Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections
por: Balkhair, A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mkfjm8qmkp6ns5mghnpn9oo3ro